Clinical Mass Spectrometry in Immunosuppressant Analysis: Toward a Full Automation?

The analysis of immunosuppressive drugs allows the physician to monitor, and eventually correct, immunosuppressive therapy. The panel of molecules under evaluation includes cyclosporine A (CsA), tacrolimus, sirolimus, and everolimus. Initially, assays were performed by immunometric methods, but in t...

Full description

Bibliographic Details
Main Authors: Chiara Fania, Marco Bagnati, Marina Albertario, Carlotta Ferraris, Marta Lamonaca, Umberto Dianzani
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Applied Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3417/12/7/3695
_version_ 1797440240285122560
author Chiara Fania
Marco Bagnati
Marina Albertario
Carlotta Ferraris
Marta Lamonaca
Umberto Dianzani
author_facet Chiara Fania
Marco Bagnati
Marina Albertario
Carlotta Ferraris
Marta Lamonaca
Umberto Dianzani
author_sort Chiara Fania
collection DOAJ
description The analysis of immunosuppressive drugs allows the physician to monitor, and eventually correct, immunosuppressive therapy. The panel of molecules under evaluation includes cyclosporine A (CsA), tacrolimus, sirolimus, and everolimus. Initially, assays were performed by immunometric methods, but in the past few years this methodology has been largely superseded by a more accurate and specific technique, liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS), which is now considered the “gold standard” for immunosuppressant analysis. Both LC-MS/MS and often also immunoassays require a preanalytical manual sample preparation, which involves time-consuming sequential operations whose traceability is often hampered and adds up to the probability of gross errors. The aim of this work was to compare an “open” LC-MS/MS with a fully automated system, consisting of LC instrumentation combined with a triple quadrupole MS, named Thermo Scientific<sup>TM</sup> Cascadion<sup>TM</sup> SM Clinical Analyzer (Cascadion). Such automated systems suit the requirements of the reference method and are designed to completely eliminate all of the manual procedures. More than 2000 immunosuppressant samples were analyzed both with the open LC-MS/MS and with Cascadion. Statistics allowed the evaluation of linearity, intra- and inter-assay CV%, bias %, limit of detection and of quantitation, and Passing–Bablok and Bland–Altman plots. Results indicated a good correlation between the two methods. In both cases, methods confirmed their suitability for diagnostic settings. Cascadion could provide support when the presence of specialized personnel is lacking, and/or when great productivity and continuous workflow are required.
first_indexed 2024-03-09T12:04:18Z
format Article
id doaj.art-077706c8b0414c709cbd3645393a058c
institution Directory Open Access Journal
issn 2076-3417
language English
last_indexed 2024-03-09T12:04:18Z
publishDate 2022-04-01
publisher MDPI AG
record_format Article
series Applied Sciences
spelling doaj.art-077706c8b0414c709cbd3645393a058c2023-11-30T22:59:15ZengMDPI AGApplied Sciences2076-34172022-04-01127369510.3390/app12073695Clinical Mass Spectrometry in Immunosuppressant Analysis: Toward a Full Automation?Chiara Fania0Marco Bagnati1Marina Albertario2Carlotta Ferraris3Marta Lamonaca4Umberto Dianzani5Clinical Chemistry Laboratory, Maggiore della Carità University Hospital, 28100 Novara, ItalyClinical Chemistry Laboratory, Maggiore della Carità University Hospital, 28100 Novara, ItalyClinical Chemistry Laboratory, Maggiore della Carità University Hospital, 28100 Novara, ItalyClinical Chemistry Laboratory, Maggiore della Carità University Hospital, 28100 Novara, ItalyIRCAD & Department of Health Sciences, Amedeo Avogadro University of Eastern Piedmont, 28100 Novara, ItalyClinical Chemistry Laboratory, Maggiore della Carità University Hospital, 28100 Novara, ItalyThe analysis of immunosuppressive drugs allows the physician to monitor, and eventually correct, immunosuppressive therapy. The panel of molecules under evaluation includes cyclosporine A (CsA), tacrolimus, sirolimus, and everolimus. Initially, assays were performed by immunometric methods, but in the past few years this methodology has been largely superseded by a more accurate and specific technique, liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS), which is now considered the “gold standard” for immunosuppressant analysis. Both LC-MS/MS and often also immunoassays require a preanalytical manual sample preparation, which involves time-consuming sequential operations whose traceability is often hampered and adds up to the probability of gross errors. The aim of this work was to compare an “open” LC-MS/MS with a fully automated system, consisting of LC instrumentation combined with a triple quadrupole MS, named Thermo Scientific<sup>TM</sup> Cascadion<sup>TM</sup> SM Clinical Analyzer (Cascadion). Such automated systems suit the requirements of the reference method and are designed to completely eliminate all of the manual procedures. More than 2000 immunosuppressant samples were analyzed both with the open LC-MS/MS and with Cascadion. Statistics allowed the evaluation of linearity, intra- and inter-assay CV%, bias %, limit of detection and of quantitation, and Passing–Bablok and Bland–Altman plots. Results indicated a good correlation between the two methods. In both cases, methods confirmed their suitability for diagnostic settings. Cascadion could provide support when the presence of specialized personnel is lacking, and/or when great productivity and continuous workflow are required.https://www.mdpi.com/2076-3417/12/7/3695LC-MS/MSTDMautomation
spellingShingle Chiara Fania
Marco Bagnati
Marina Albertario
Carlotta Ferraris
Marta Lamonaca
Umberto Dianzani
Clinical Mass Spectrometry in Immunosuppressant Analysis: Toward a Full Automation?
Applied Sciences
LC-MS/MS
TDM
automation
title Clinical Mass Spectrometry in Immunosuppressant Analysis: Toward a Full Automation?
title_full Clinical Mass Spectrometry in Immunosuppressant Analysis: Toward a Full Automation?
title_fullStr Clinical Mass Spectrometry in Immunosuppressant Analysis: Toward a Full Automation?
title_full_unstemmed Clinical Mass Spectrometry in Immunosuppressant Analysis: Toward a Full Automation?
title_short Clinical Mass Spectrometry in Immunosuppressant Analysis: Toward a Full Automation?
title_sort clinical mass spectrometry in immunosuppressant analysis toward a full automation
topic LC-MS/MS
TDM
automation
url https://www.mdpi.com/2076-3417/12/7/3695
work_keys_str_mv AT chiarafania clinicalmassspectrometryinimmunosuppressantanalysistowardafullautomation
AT marcobagnati clinicalmassspectrometryinimmunosuppressantanalysistowardafullautomation
AT marinaalbertario clinicalmassspectrometryinimmunosuppressantanalysistowardafullautomation
AT carlottaferraris clinicalmassspectrometryinimmunosuppressantanalysistowardafullautomation
AT martalamonaca clinicalmassspectrometryinimmunosuppressantanalysistowardafullautomation
AT umbertodianzani clinicalmassspectrometryinimmunosuppressantanalysistowardafullautomation